Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Dalla Lana School of Public Health, University of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.
BMJ Open. 2023 Jul 19;13(7):e066201. doi: 10.1136/bmjopen-2022-066201.
The age-standardised suicide mortality rate in Thailand has been stable at a high level in recent years, highlighting the need for suicide prevention interventions. In Thailand, community involvement plays a key role in health promotion. The aim of this ongoing trial is to evaluate the efficacy of a community participatory intervention in two subdistricts in Thailand for reducing suicidality symptoms among individuals considered at high risk for suicide and compare the outcomes to two control subdistricts.
In this cluster (subdistrict) randomised controlled trial, we randomised two districts to either the community participatory intervention arm or the control arm. From each district, we selected one large and one small subdistricts. We estimated that we need 235 participants per study arm, who were recruited from subdistrict health centres. The primary outcome is suicidality symptoms. Secondary outcomes are depression symptoms, quality of life, stress level and health and community service accessibility.
This trial has been approved by the Research Ethics Committee, Faculty of Nursing, Chiangmai University (number 050/2022). All participants were required to provide informed consent. The findings of the study will be disseminated in peer-reviewed journals and via conferences.
TCTR20220620003; the Thai Clinical Trials Registry.
近年来，泰国的标准化自杀死亡率一直保持在较高水平，这凸显了需要进行自杀预防干预。在泰国，社区参与在促进健康方面发挥着关键作用。本正在进行的试验旨在评估一种社区参与式干预在泰国两个分区中的效果，以减少被认为有自杀风险的个体的自杀意念症状，并将结果与两个对照分区进行比较。
在这项集群（分区）随机对照试验中，我们将两个区随机分配到社区参与式干预组或对照组。从每个区中，我们选择一个大分区和一个小分区。我们估计每个研究组需要招募 235 名参与者，他们是从分区卫生中心招募的。主要结局是自杀意念症状。次要结局是抑郁症状、生活质量、压力水平以及卫生和社区服务的可及性。
这项试验已获得清迈大学护理学院研究伦理委员会（编号 050/2022）的批准。所有参与者都需要提供知情同意书。研究结果将在同行评议的期刊和会议上发表。
TCTR20220620003；泰国临床试验注册处。
